To amend the Federal Food, Drug, and Cosmetic Act to provide a process to lock and suspend domain names used to facilitate the online sale of drugs illegally, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Federal Food, Drug, and Cosmetic Act to provide a process to lock and suspend domain names used to facilitate the online sale of drugs illegally, and for other purposes., changes federal law or congressional policy affecting technology companies and users of digital services. The main policy domain is Technology, Immigration, Healthcare.
Who Benefits and How
technology companies and users of digital services may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, technology companies and users of digital services may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HE1178F26BEFE4462B50B62BAB3380CAC: 1. Short title This Act may be cited as the Domain Reform for Unlawful Drug Sellers Act or the DRUGS Act.
- Section HB3346A8706684BDAAFF7A5C691FBE01C: 2. Domain names used to facilitate the online sale of drugs illegally Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351 et...
- Section H9D39E0A7FE4F4C27A4228723D4337B62: 524C. Domain names used to facilitate the online sale of drugs illegally A registry operator or registrar shall— not later than 24 hours after receipt of a...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Federal Food, Drug, and Cosmetic Act to provide a process to lock and suspend domain names used to facilitate the online sale of drugs illegally, and for other purposes., changes federal law or congressional policy affecting technology companies and users of digital services.
Key Policy Areas
Technology, Immigration, Healthcare
Primary Purpose
This bill, To amend the Federal Food, Drug, and Cosmetic Act to provide a process to lock and suspend domain names used to facilitate the online sale of drugs illegally, and for other purposes., changes federal law or congressional policy affecting technology companies and users of digital services.
Policy Domains
Whole bill
Identified Gains
- technology companies and users of digital services
Identified Costs
- federal implementing agencies
- technology companies and users of digital services
Sponsors
Legislative Progress
IntroducedMr. Rubio introduced the following bill; which was read twice …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
Key Definitions
Terms defined in this bill
an authoritative master database of the domain names registered in a top-level domain. The term registry operator means an organization that maintains a registry, including by— receiving requests from registrars to add, delete, or modify domain names
an authoritative master database of the domain names registered in a top-level domain. The term registry operator means an organization that maintains a registry, including by— receiving requests from registrars to add, delete, or modify domain names
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology